Insider · CIK 0001861926
SAHA SAURABH
ceoofficerdirector
Files at CNTA (Centessa Pharmaceuticals plc). First filing Oct 23, 2024, latest Dec 20, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $5.1M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 44Moderate | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | $959k | 55,000 | -10% | - | |
| 35Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | $1.6M | 87,496 | -13% | - | |
| 0Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | $5,451 | 299 | -0% | - | |
| 23Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | $1.0M | 60,182 | -10% | - | |
| 17Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | $585k | 32,023 | -5% | - | |
| 36Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | $864k | 55,000 | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | CNTA Centessa Pharmaceuticals plc | FTax withholding Ordinary Shares | -36,263 | $16.35 | $593k | 484,398 | Dec 31, 2024 |
| Dec 20, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -55,000 | $17.44 | $959k | 520,661 | Dec 20, 2024 |
| Dec 6, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +87,496 | $5.84 | $511k | 663,157 | Dec 6, 2024 |
| Dec 6, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -87,496 | $18.46 | $1.6M | 575,661 | Dec 6, 2024 |
| Dec 6, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -87,496 | $0.00 | $0 | 3,869,485 | Dec 6, 2024 |
| Nov 25, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +299 | $5.84 | $1,746 | 575,960 | Nov 27, 2024 |
| Nov 25, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -299 | $18.23 | $5,451 | 575,661 | Nov 27, 2024 |
| Nov 25, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -299 | $0.00 | $0 | 3,956,981 | Nov 27, 2024 |
| Nov 20, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -55,000 | $16.89 | $929k | 575,661 | Nov 22, 2024 |
| Nov 21, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares | +3,511 | $5.84 | $21k | 579,172 | Nov 22, 2024 |
| Nov 21, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -3,511 | $18.24 | $64k | 575,661 | Nov 22, 2024 |
| Nov 22, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares | +1,671 | $5.84 | $9,759 | 577,332 | Nov 22, 2024 |
| Nov 22, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -1,671 | $18.24 | $30k | 575,661 | Nov 22, 2024 |
| Nov 21, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative | -3,511 | $0.00 | $0 | 3,958,951 | Nov 22, 2024 |
| Nov 22, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative | -1,671 | $0.00 | $0 | 3,957,280 | Nov 22, 2024 |
| Nov 13, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +32,023 | $5.84 | $187k | 662,684 | Nov 15, 2024 |
| Nov 13, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -32,023 | $18.28 | $585k | 630,661 | Nov 15, 2024 |
| Nov 13, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -32,023 | $0.00 | $0 | 3,962,462 | Nov 15, 2024 |
| Oct 21, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -22,205 | $15.80 | $351k | 663,456 | Oct 23, 2024 |
| Oct 22, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -30,203 | $15.67 | $473k | 633,253 | Oct 23, 2024 |
| Oct 23, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -2,592 | $15.32 | $40k | 630,661 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.